Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pedro Santos-Moreno, Gabriel-Santiago Rodríguez-Vargas, Susan Martínez, Linda Ibatá & Adriana Rojas-Villarraga. (2022) Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications. Open Access Rheumatology: Research and Reviews 14, pages 255-267.
Read now
Read now
Lihui Wen, Ji-Hyoun Kang, Yi-Rang Yim, Jeong-Won Lee, Kyung-Eun Lee, Dong-Jin Park, Tae-Jong Kim, Yong-Wook Park & Shin-Seok Lee. (2016) Risk factors for treatment failure in osteoporotic patients with rheumatoid arthritis. Modern Rheumatology 26:2, pages 194-199.
Read now
Read now
Marco Krasselt & Christoph Baerwald. (2014) The current relevance and use of prednisone in rheumatoid arthritis. Expert Review of Clinical Immunology 10:5, pages 557-571.
Read now
Read now
Cecilia Mercieca & John R Kirwan. (2014) The intelligent use of systemic glucocorticoids in rheumatoid arthritis. Expert Review of Clinical Immunology 10:1, pages 143-157.
Read now
Read now
C Book, MK Karlsson, J-Å Nilsson, K Åkesson & LTH Jacobsson. (2011) Changes in body composition after 2 years with rheumatoid arthritis. Scandinavian Journal of Rheumatology 40:2, pages 95-100.
Read now
Read now
Articles from other publishers (42)
Sofia Ajeganova, Maria Andersson, Kristina Forslind, Inger Gjertsson, Britt-Marie Nyhäll-Wåhlin, Björn Svensson & Ingiäld Hafström. (2023) Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years. BMC Rheumatology 7:1.
Crossref
Crossref
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco & Frank Buttgereit. (2022) Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Annals of the Rheumatic Diseases 81:9, pages 1313-1322.
Crossref
Crossref
Rahaf Baker, Radhika Narla, Joshua F. Baker & Katherine D. Wysham. (2022) Risk factors for osteoporosis and fractures in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 36:3, pages 101773.
Crossref
Crossref
Hong Huang, Yu Wang, Wenhui Xie, Yan Geng, Dai Gao & Zhuoli Zhang. (2022) Impact of Treat-to-Target Therapy on Bone Mineral Density Loss in Patients With Rheumatoid Arthritis: A Prospective Cohort Study. Frontiers in Endocrinology 13.
Crossref
Crossref
Katherine D. Wysham, Jane Shofer, Gabriella Lui, Laura Trupin, James S. Andrews, Dennis M. Black, Jonathan Graf, Dolores M. Shoback & Patricia P. Katz. (2022) Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort. Seminars in Arthritis and Rheumatism 53, pages 151972.
Crossref
Crossref
Peter R Ebeling, Hanh H Nguyen, Jasna Aleksova, Amanda J Vincent, Phillip Wong & Frances Milat. (2022) Secondary Osteoporosis. Endocrine Reviews 43:2, pages 240-313.
Crossref
Crossref
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim & Chang-Hee Suh. (2021) Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine 10:13, pages 2944.
Crossref
Crossref
Hamida Azzouzi & Linda Ichchou. (2021) Bone Loss and Radiographic Damage Profile in Rheumatoid Arthritis Moroccan Patients. Journal of Bone Metabolism 28:2, pages 151-159.
Crossref
Crossref
Katherine D. Wysham, Joshua F. Baker & Dolores M. Shoback. (2021) Osteoporosis and fractures in rheumatoid arthritis. Current Opinion in Rheumatology 33:3, pages 270-276.
Crossref
Crossref
Carmen Gómez-Vaquero, Irene Martín, Andrea Zacarías, Pedro Alía, Estíbaliz Loza, Loreto Carmona & Javier Narváez. (2021) Relation of the Serum Levels of DKK-1 and Osteoprotegerin with Bone Mass in Tightly Controlled Rheumatoid Arthritis. Current Rheumatology Reviews 17:1, pages 101-108.
Crossref
Crossref
O. V. Dobrovolskaya, O. A. Nikitinskaya, A. O. Efremova, N. V. Dyomin, N. V. Toroptsova & А. Yu. Feklistov. (2021) Body composition phenotypes in rheumatoid arthritis. Medical alphabet:31, pages 5-8.
Crossref
Crossref
Debolina Chakraborty, Kriti Gupta & Sagarika Biswas. (2021) A mechanistic insight of phytoestrogens used for Rheumatoid arthritis: An evidence-based review. Biomedicine & Pharmacotherapy 133, pages 111039.
Crossref
Crossref
Anett Vincze, Levente Bodoki, Katalin Szabó, Melinda Nagy-Vincze, Orsolya Szalmás, József Varga, Katalin Dankó, János Gaál & Zoltán Griger. (2020) The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center. BMC Musculoskeletal Disorders 21:1.
Crossref
Crossref
Lisa Theander, Minna Willim, Jan Åke Nilsson, Magnus Karlsson, Kristina E Åkesson, Lennart T H Jacobsson & Carl Turesson. (2020) Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis. RMD Open 6:1, pages e001142.
Crossref
Crossref
Chung-Yuan Hsu, Jia-Feng Chen, Yu-Jih Su, Ying-Chou Chen, Han-Ming Lai, Shan-Fu Yu, Hsiao-Ru He & Tien-Tsai Cheng. (2020) Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes. Therapeutic Advances in Chronic Disease 11, pages 204062232098151.
Crossref
Crossref
Hennie G. Raterman & Willem F. Lems. (2019) Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide. Drugs & Aging 36:12, pages 1061-1072.
Crossref
Crossref
Hana Ben Hassine, Ramzi Zemni, Imen Ben Nacef, Asma Boumiza, Foued Slama, Khadija Baccouche, Najla Amri, Sarra Melayah, Zahid Shakoor, Adel Almogren, Elyes Bouajina & Rim Sghiri. (2018) A TRAF6 genetic variant is associated with low bone mineral density in rheumatoid arthritis. Clinical Rheumatology 38:4, pages 1067-1074.
Crossref
Crossref
Pier Paolo Sainaghi & Antonello Gibbin. (2018) Vitamin D, Inflammation and Osteoporosis in Rheumatoid Arthritis. The Open Rheumatology Journal 12:1, pages 300-312.
Crossref
Crossref
Melek Güler-Yüksel, Jos N. Hoes, Irene E.M. Bultink & Willem F. Lems. (2018) Glucocorticoids, Inflammation and Bone. Calcified Tissue International 102:5, pages 592-606.
Crossref
Crossref
Yi-Ming Chen, Hsin-Hua Chen, Wen-Nan Huang, Tsai-Ling Liao, Jun-Peng Chen, Wen-Cheng Chao, Ching-Tsai Lin, Wei-Ting Hung, Chia-Wei Hsieh, Tsu-Yi Hsieh, Yi-Hsing Chen & Der-Yuan Chen. (2017) Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLOS ONE 12:11, pages e0188454.
Crossref
Crossref
M. H. Han, J. I. Ryu, C. H. Kim, J. M. Kim, J. H. Cheong, K. H. Bak & H. J. Chun. (2017) Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis. Osteoporosis International 28:6, pages 1931-1938.
Crossref
Crossref
Jianhua Peng, Yao Gong, Yuping Zhang, Zhengyu Xiao, Qingyu Zeng & Subiao Chen. (2016) Bone Mineral Density in Patients With Rheumatoid Arthritis and 4-Year Follow-up Results. JCR: Journal of Clinical Rheumatology 22:2, pages 71-74.
Crossref
Crossref
Kiyoshi Migita, Nozomi Iwanaga, Shunsuke Imadachi, Yuka Jiuchi, Yasumori Izumi, Yoshika Tsuji, Chieko Kawahara, Atsushi Kawakami, Hiroshi Furukawa & Shigeto Tohma. (2015) Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy. Medicine 94:27, pages e875.
Crossref
Crossref
S. Berglundh, L. Malmgren, H. Luthman, F. McGuigan & K. Åkesson. (2014) C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort. Osteoporosis International 26:2, pages 727-735.
Crossref
Crossref
Li-Xia Gao. (2015) Osteoporosis in rheumatic diseases. World Journal of Rheumatology 5:1, pages 23.
Crossref
Crossref
John L. Gillick, John Wainwright & Kaushik Das. (2015) Rheumatoid Arthritis and the Cervical Spine: A Review on the Role of Surgery. International Journal of Rheumatology 2015, pages 1-12.
Crossref
Crossref
Voja Pavlovic, Aleksandar Dimic, Sasa Milenkovic, Dane Krtinic & Ivana Aleksic. (2014) Relation between bone mineral density
and IL-17 serum levels in Serbian patients with
early Rheumatoid arthritis. Open Medicine 10:1.
Crossref
Crossref
Marlies C van der Goes, Johannes W Jacobs & Johannes W Bijlsma. (2014) The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects. Arthritis Research & Therapy 16:S2.
Crossref
Crossref
N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens & J W J Bijlsma. (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases 72:12, pages 1905-1913.
Crossref
Crossref
M. C. van der Goes, J. W. G. Jacobs, M. S. Jurgens, M. F. Bakker, M. J. van der Veen, J. H. van der Werf, P. M. J. Welsing & J. W. J. Bijlsma. (2012) Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?. Osteoporosis International 24:4, pages 1429-1436.
Crossref
Crossref
Anna Straburzyńska-Lupa, Alicja Nowak, Wojciech Romanowski, Paweł Korman & Łucja Pilaczyńska-Szcześniak. (2012) A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis. Journal of Bone and Mineral Metabolism 31:2, pages 169-176.
Crossref
Crossref
Norma J. MacIntyre, Monique E. MullerColin E. Webber & Jonathan D. Adachi. (2012) The Relationship between Radial Bone Properties and Disease Activity and Physical Function in Individuals with Rheumatoid Arthritis. Physiotherapy Canada 64:3, pages 284-291.
Crossref
Crossref
Danieli Castro Oliveira de Andrade, Sonia Cristina de Magalhães Souza, Jozélio Freire de Carvalho, Liliam Takayama, Claudia Teresa Lobato Borges, José Mendes Aldrighi & Rosa Maria Rodrigues Pereira. (2011) High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis. Rheumatology International 32:6, pages 1549-1553.
Crossref
Crossref
L. Dirven, M. Güler‐Yüksel, W. M. de Beus, H. K. Ronday, I. Speyer, T. W. J. Huizinga, B. A. C. Dijkmans, C. F. Allaart & W. F. Lems. (2011) Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in a multicenter randomized clinical trial. Arthritis Care & Research 63:12, pages 1691-1699.
Crossref
Crossref
Hanh-Hung Dao, Quan-Trung Do & Junichi Sakamoto. (2011) Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clinical Rheumatology 30:10, pages 1353-1361.
Crossref
Crossref
Takefumi Furuya, Takayuki Hosoi, Seiji Saito, Eisuke Inoue, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2011) Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis. Clinical Rheumatology 30:8, pages 1105-1111.
Crossref
Crossref
Cathleen Colón‐Emeric, Mary Beth O'Connell & Elizabeth Haney. (2011) Osteoporosis Piece of Multi‐Morbidity Puzzle in Geriatric Care. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:4, pages 515-526.
Crossref
Crossref
Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho & Ernesto Canalis. (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics 65:11, pages 1197-1205.
Crossref
Crossref
Kathleen A. Bishop, Mark B. Meyer & J. Wesley Pike. (2009) A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression. Molecular Endocrinology 23:12, pages 2095-2110.
Crossref
Crossref
C. Book, J. Algulin, J.-A. Nilsson, T. Saxne & L. Jacobsson. (2009) Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis. Rheumatology 48:9, pages 1088-1091.
Crossref
Crossref
C. Book, M. K. Karlsson, K. Akesson & L. T. H. Jacobsson. (2009) Early rheumatoid arthritis and body composition. Rheumatology 48:9, pages 1128-1132.
Crossref
Crossref
Reiner Bartl & Bertha FrischReiner Bartl & Bertha Frisch. 2009. Osteoporosis. Osteoporosis
203
214
.